title: Analysis of survival parameters of patients with hematological malignancies in Saint Petersburg at the population level
metadata.name: dc.contributor.author
metadata.value: Zhiguleva, Lubov U.
metadata.lang: -
metadata.name: dc.contributor.author
metadata.value: Abdulkadyrov, Кudrat М.
metadata.lang: -
metadata.name: dc.date.accessioned
metadata.value: 2017-01-27T14:52:16Z
metadata.lang: -
metadata.name: dc.date.available
metadata.value: 2017-01-27T14:52:16Z
metadata.lang: -
metadata.name: dc.date.issued
metadata.value: 2016-09
metadata.lang: -
metadata.name: dc.identifier.citation
metadata.value: Zhiguleva L. Y u., Abdulkadyrov K. M. Analysis of survival parameters of patients with hematological malignancies in Saint Petersburg at the population level. Vestnik of Saint Petersburg University. Series 11. Medicine, 2016, issue 3, pp. 111–121.
metadata.lang: en_GB
metadata.name: dc.identifier.other
metadata.value: 10.21638/11701/spbu11.2016.311
metadata.lang: -
metadata.name: dc.identifier.uri
metadata.value: http://hdl.handle.net/11701/5966
metadata.lang: -
metadata.name: dc.description.abstract
metadata.value: This article presents an analysis of changing parameters of cumulative 5-year survival, corrected and
  relative survival of patients with various hematological malignancies in Saint-Petersburg with the
  population divided in relation to sex, age, and the time of diagnosis (for 1996–1999, 2000–2003 and
  2004–2007). The study was conducted according to the database of the Population Cancer Register
  (PCR) of Saint-Petersburg. Parameters were calculated with the actuarial method using the PCR software
  complex. Positive survival changes were noted in patients with Hodgkins lymphoma, multiple
  myeloma, acute lymphoblastic leukemia (<18 years-old group (y. o.)), chronic lymphoid leukemia,
  chronic myeloid leukemia (<60 y. o.); negative changes were observed in acute myeloid leukemia, acute lymphoblastic leukemia (≥18 y. o.), chronic myeloid leukemia (≥60 y. o.). Male survival was lower in
  the majority of hematological malignancies compared to female survival. Positive survival changes indicate
  the efficacy of the programmed treatment of hematological malignancies. The most striking increase
  of patient survival was noted for those diagnosed in years 2004–2007, which may be explained
  by the use of highly efficient target drugs of the latest generations. Patients’ age had the most significant
  impact on survival parameters. Refs 8. Tables 8.
metadata.lang: en_GB
metadata.name: dc.language.iso
metadata.value: ru
metadata.lang: en_GB
metadata.name: dc.publisher
metadata.value: St Petersburg State University
metadata.lang: en_GB
metadata.name: dc.relation.ispartofseries
metadata.value: Vestnik of St Petersburg University. Series 11. Medicine;Issue 3
metadata.lang: -
metadata.name: dc.subject
metadata.value: survival
metadata.lang: en_GB
metadata.name: dc.subject
metadata.value: hematological malignancies
metadata.lang: en_GB
metadata.name: dc.subject
metadata.value: population level
metadata.lang: en_GB
metadata.name: dc.title
metadata.value: Analysis of survival parameters of patients with hematological malignancies in Saint Petersburg at the population level
metadata.lang: en_GB
metadata.name: dc.type
metadata.value: Article
metadata.lang: en_GB
resources.filename: 11-Zhiguleva.pdf
resources.url: https://dspace.spbu.ru/bitstream/11701/5966/1/11-Zhiguleva.pdf
resources.format: Adobe PDF
resources.size: 524,45 kB